SEMA3F and colorectal carcinoma: Our previous study demonstrated that SEMA3F signaling may contribute to reversing chemotherapy resistance in CRC cells (21), so we first verified the expression of SEMA3F in a series of CRC cell lines: HCT-116, LS174T, HT-29, SW480, SW620, LoVo and RKO cells (Figure 1A).